http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105283183-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 |
| filingDate | 2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105283183-B |
| titleOfInvention | Ophthalmic composition for zwitterionic soft contact lens |
| abstract | The object of the present invention is to provide an ophthalmic composition for zwitterionic SCL comprising pranoprofen and/or a salt thereof, which exhibits a clear appearance and suppresses the effect of pranoprofen and/or a salt thereof on the zwitterion. Adsorption technology of sexual SCL. By adding chondroitin sulfate and/or a salt thereof to an ophthalmic composition for zwitterionic SCL containing pranoprofen and/or a salt thereof, and setting the pH to 5.5 or higher, a clear appearance property can be realized , and can effectively inhibit the adsorption of pranoprofen and/or its salt to zwitterionic SCL. |
| priorityDate | 2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.